364
Views
29
CrossRef citations to date
0
Altmetric
Original Research

The use of augmented reality glasses in central line simulation: “see one, simulate many, do one competently, and teach everyone”

, , , , , , & show all
Pages 357-363 | Published online: 10 May 2018
 

Abstract

Objective

The aim of this study was to investigate the feasibility of using augmented reality (AR) glasses in central line simulation by novice operators and compare its efficacy to standard central line simulation/teaching.

Design

This was a prospective randomized controlled study enrolling 32 novice operators. Subjects were randomized on a 1:1 basis to either simulation using the augmented virtual reality glasses or simulation using conventional instruction.

Setting

The study was conducted in tertiary-care urban teaching hospital.

Subjects

A total of 32 adult novice central line operators with no visual or auditory impairments were enrolled. Medical doctors, respiratory therapists, and sleep technicians were recruited from the medical field.

Measurements and main results

The mean time for AR placement in the AR group was 71±43 s, and the time to internal jugular (IJ) cannulation was 316±112 s. There was no significant difference in median (minimum, maximum) time (seconds) to IJ cannulation for those who were in the AR group and those who were not (339 [130, 550] vs 287 [35, 475], p=0.09), respectively. There was also no significant difference between the two groups in median total procedure time (524 [329, 792] vs 469 [198, 781], p=0.29), respectively. There was a significant difference in the adherence level between the two groups favoring the AR group (p=0.003).

Conclusion

AR simulation of central venous catheters in manikins is feasible and efficacious in novice operators as an educational tool. Future studies are recommended in this area as it is a promising area of medical education.

Acknowledgments

We are indebted to Brother International Corp., Bridgewater, NJ, USA, Tom & Vi Zapara School of Business at La Sierra University and Loma Linda University Ignis Medical Innovations (IMI) for their their support during this study.

Disclosure

The authors report no conflicts of interest in this work.